Affordable Access

Publisher Website

Enhanced anti-HCV activity of interferon alpha 17 subtype

Authors
Journal
Virology Journal
1743-422X
Publisher
Springer (Biomed Central Ltd.)
Publication Date
Volume
6
Issue
1
Identifiers
DOI: 10.1186/1743-422x-6-70
Keywords
  • Research
Disciplines
  • Medicine

Abstract

Background Pegylated interferon alpha 2 (a or b) plus ribavirin is the most effective treatment of chronic hepatitis C but a large proportion of patients do not respond to therapy. So, it is interesting to improve the treatment efficacy. Interferon alpha is a type I interferon composed of 12 different subtypes. Each subtype signals by the Jak-Stat pathway but modulations in the antiviral activity was previously described. Methods Using the hepatitis C virus (HCV) culture system, we have tested the anti-HCV activity of each interferon alpha subtypes. We have analyzed the effect of each subtype on the HCV multiplication and the cell-signaling pathway for some subtypes. Results There were divergent effects of IFN alpha subtypes against HCV. We have found that IFN alpha 17 was three times more efficient than IFN alpha 2a on HCV. This efficiency was related to a stronger stimulation of the Jak-Stat pathway. Conclusion We suggest that IFN α17 should be tested therapeutically with a view to improving treatment efficacy.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

The antiprostatic activity of 17Alpha-ethynyl-2-an...

on Cancer chemotherapy reports. P... September 1962

Interferon alpha therapy in patients with chronic...

on The Korean journal of internal... January 1992

Serum hepatitis C virus (HCV)-RNA and response to...

on Journal of Medical Virology November 1992
More articles like this..